Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Tetrahydrouridine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 35 Cyclophosphamide 21 Bevacizumab 16 Standard of Care 12 Nivolumab 12 Carboplatin 12 Blood Specimen Collection 12 atezolizumab 11 Paclitaxel 10 Doxorubicin 10 Rituximab 9 Pemetrexed 9 Interviews as Topic 9 Fluorouracil 9 fludarabine 8 Prednisone 8 Surveys and Questionnaires 7 Radiotherapy 7 Oxaliplatin 7 Leucovorin 7 Dexamethasone 7 venetoclax 6 olaparib 6 durvalumab 6 Letrozole 6 Fulvestrant 6 Exercise 6 Biopsy 6 pertuzumab 5 palbociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01534598 2026-02-10

FdCyd and THU for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡